Historical record - last NADAC publication: 1/1/2017
Product Information
ACTEMRA 162 MG/0.9 ML SYRINGE is a brand product labeled by Genentech, Inc., priced at $1001.1205 per ML under NDC 50242013801. Its NADAC has been published 135 times since Jun 18, 2014.
Strength
162 mg/.9mL
Manufacturer
Genentech, Inc.NDC
50242013801
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/1/2017
Active Ingredients
TOCILIZUMABApproval Type
Biologic (BLA)
FDA Application
BLA125472On Market Since
10/21/2013
Pharmacological Classes
Price Statistics
The NADAC for ACTEMRA 162 MG/0.9 ML SYRINGE has been published 135 times since Jun 18, 2014, and over the history we have for it it has risen 46.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1001.1205 per ML |
|---|---|
| All-time high | $1001.1205 (Jan 11, 2017) |
| All-time low | $683.0533 (Jun 18, 2014) |
| Median price | $827.2625 |
| Average price | $823.2715 |
| Largest weekly change | +8.0% (Jul 8, 2015) |
| Weeks tracked | 135 |
| Tracking since | Jun 18, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACTEMRA 162 MG/0.9 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for ACTEMRA 162 MG/0.9 ML SYRINGE, manufactured by Genentech, Inc., is $1001.1205 per ML (NDC 50242013801), effective Jan 11, 2017.
How has the price of ACTEMRA 162 MG/0.9 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for ACTEMRA 162 MG/0.9 ML SYRINGE has risen 46.6%. It has been tracked across 135 weekly CMS publications since Jun 18, 2014.
What are the highest and lowest recorded NADAC prices for ACTEMRA 162 MG/0.9 ML SYRINGE?
Since Jun 18, 2014, the NADAC for ACTEMRA 162 MG/0.9 ML SYRINGE has ranged from a low of $683.0533 (Jun 18, 2014) to a high of $1001.1205 (Jan 11, 2017), with a median of $827.2625 per ML.
Are there cheaper alternatives to ACTEMRA 162 MG/0.9 ML SYRINGE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ACTEMRA 162 MG/0.9 ML SYRINGE, but none are currently priced below it.
Who manufactures ACTEMRA 162 MG/0.9 ML SYRINGE?
ACTEMRA 162 MG/0.9 ML SYRINGE (NDC 50242013801) is labeled by Genentech, Inc., and CMS classifies it as a brand product.